container_end_page 365
container_issue 3
container_start_page 364
container_title Southern medical journal (Birmingham, Ala.)
container_volume 90
creator Fleming, D R
Mangino, P B
description
doi_str_mv 10.1097/00007611-199703000-00022
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00007611_199703000_00022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>9076316</sourcerecordid><originalsourceid>FETCH-LOGICAL-c279t-d7967e4ccf66a039b78f4d2a802c0265d570d3d0367f2ae115e08e4ee4f682a83</originalsourceid><addsrcrecordid>eNo9kF1LwzAUhnOhzDn9CUL-QDRp2iS9lOEXDPRCr0vWnKxxTVOSVui_t3NzBw6HF97nXDwIYUbvGS3lA51HCsYIK0tJ-ZzIvFl2gZaUckVynqsrdJ3S96FYKLFAi3ImOBNLtP_Qce-6FDqnO5ymzsTgAbsOa2ycbqfkEklj34c4gMG9Hhx0A45Qg_tx3Q43btcQExLgugEfhgai7idsQ8R-bAfXt4D9BG3w-gZdWt0muD3dFfp6fvpcv5LN-8vb-nFD6kyWAzGyFBLyurZCaMrLrVQ2N5lWNKtpJgpTSGq4oVxIm2lgrACqIAfIrVBzja-QOv6tY0gpgq366LyOU8VodVBW_SurzsqqP2UzendE-3HrwZzBky_-C0wba5g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Parkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Fleming, D R ; Mangino, P B</creator><creatorcontrib>Fleming, D R ; Mangino, P B</creatorcontrib><identifier>ISSN: 0038-4348</identifier><identifier>DOI: 10.1097/00007611-199703000-00022</identifier><identifier>PMID: 9076316</identifier><language>eng</language><publisher>United States</publisher><subject>Antineoplastic Agents, Alkylating - administration &amp; dosage ; Antineoplastic Agents, Alkylating - adverse effects ; Antineoplastic Agents, Phytogenic - administration &amp; dosage ; Antineoplastic Agents, Phytogenic - adverse effects ; Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage ; Antineoplastic Combined Chemotherapy Protocols - adverse effects ; Cyclophosphamide - administration &amp; dosage ; Cyclophosphamide - adverse effects ; Etoposide - administration &amp; dosage ; Etoposide - adverse effects ; Hemofiltration ; Humans ; Immunoglobulin kappa-Chains ; Male ; Middle Aged ; Multiple Myeloma - drug therapy ; Parkinson Disease, Secondary - chemically induced ; Renal Insufficiency - complications ; Renal Insufficiency - therapy</subject><ispartof>Southern medical journal (Birmingham, Ala.), 1997-03, Vol.90 (3), p.364-365</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c279t-d7967e4ccf66a039b78f4d2a802c0265d570d3d0367f2ae115e08e4ee4f682a83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9076316$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fleming, D R</creatorcontrib><creatorcontrib>Mangino, P B</creatorcontrib><title>Parkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma</title><title>Southern medical journal (Birmingham, Ala.)</title><addtitle>South Med J</addtitle><subject>Antineoplastic Agents, Alkylating - administration &amp; dosage</subject><subject>Antineoplastic Agents, Alkylating - adverse effects</subject><subject>Antineoplastic Agents, Phytogenic - administration &amp; dosage</subject><subject>Antineoplastic Agents, Phytogenic - adverse effects</subject><subject>Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage</subject><subject>Antineoplastic Combined Chemotherapy Protocols - adverse effects</subject><subject>Cyclophosphamide - administration &amp; dosage</subject><subject>Cyclophosphamide - adverse effects</subject><subject>Etoposide - administration &amp; dosage</subject><subject>Etoposide - adverse effects</subject><subject>Hemofiltration</subject><subject>Humans</subject><subject>Immunoglobulin kappa-Chains</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multiple Myeloma - drug therapy</subject><subject>Parkinson Disease, Secondary - chemically induced</subject><subject>Renal Insufficiency - complications</subject><subject>Renal Insufficiency - therapy</subject><issn>0038-4348</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kF1LwzAUhnOhzDn9CUL-QDRp2iS9lOEXDPRCr0vWnKxxTVOSVui_t3NzBw6HF97nXDwIYUbvGS3lA51HCsYIK0tJ-ZzIvFl2gZaUckVynqsrdJ3S96FYKLFAi3ImOBNLtP_Qce-6FDqnO5ymzsTgAbsOa2ycbqfkEklj34c4gMG9Hhx0A45Qg_tx3Q43btcQExLgugEfhgai7idsQ8R-bAfXt4D9BG3w-gZdWt0muD3dFfp6fvpcv5LN-8vb-nFD6kyWAzGyFBLyurZCaMrLrVQ2N5lWNKtpJgpTSGq4oVxIm2lgrACqIAfIrVBzja-QOv6tY0gpgq366LyOU8VodVBW_SurzsqqP2UzendE-3HrwZzBky_-C0wba5g</recordid><startdate>19970301</startdate><enddate>19970301</enddate><creator>Fleming, D R</creator><creator>Mangino, P B</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19970301</creationdate><title>Parkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma</title><author>Fleming, D R ; Mangino, P B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c279t-d7967e4ccf66a039b78f4d2a802c0265d570d3d0367f2ae115e08e4ee4f682a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Antineoplastic Agents, Alkylating - administration &amp; dosage</topic><topic>Antineoplastic Agents, Alkylating - adverse effects</topic><topic>Antineoplastic Agents, Phytogenic - administration &amp; dosage</topic><topic>Antineoplastic Agents, Phytogenic - adverse effects</topic><topic>Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage</topic><topic>Antineoplastic Combined Chemotherapy Protocols - adverse effects</topic><topic>Cyclophosphamide - administration &amp; dosage</topic><topic>Cyclophosphamide - adverse effects</topic><topic>Etoposide - administration &amp; dosage</topic><topic>Etoposide - adverse effects</topic><topic>Hemofiltration</topic><topic>Humans</topic><topic>Immunoglobulin kappa-Chains</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multiple Myeloma - drug therapy</topic><topic>Parkinson Disease, Secondary - chemically induced</topic><topic>Renal Insufficiency - complications</topic><topic>Renal Insufficiency - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fleming, D R</creatorcontrib><creatorcontrib>Mangino, P B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Southern medical journal (Birmingham, Ala.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fleming, D R</au><au>Mangino, P B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma</atitle><jtitle>Southern medical journal (Birmingham, Ala.)</jtitle><addtitle>South Med J</addtitle><date>1997-03-01</date><risdate>1997</risdate><volume>90</volume><issue>3</issue><spage>364</spage><epage>365</epage><pages>364-365</pages><issn>0038-4348</issn><cop>United States</cop><pmid>9076316</pmid><doi>10.1097/00007611-199703000-00022</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0038-4348
ispartof Southern medical journal (Birmingham, Ala.), 1997-03, Vol.90 (3), p.364-365
issn 0038-4348
language eng
recordid cdi_crossref_primary_10_1097_00007611_199703000_00022
source MEDLINE; Journals@Ovid Complete
subjects Antineoplastic Agents, Alkylating - administration & dosage
Antineoplastic Agents, Alkylating - adverse effects
Antineoplastic Agents, Phytogenic - administration & dosage
Antineoplastic Agents, Phytogenic - adverse effects
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Cyclophosphamide - administration & dosage
Cyclophosphamide - adverse effects
Etoposide - administration & dosage
Etoposide - adverse effects
Hemofiltration
Humans
Immunoglobulin kappa-Chains
Male
Middle Aged
Multiple Myeloma - drug therapy
Parkinson Disease, Secondary - chemically induced
Renal Insufficiency - complications
Renal Insufficiency - therapy
title Parkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A24%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parkinsonian%20syndrome%20in%20a%20dialysis-supported%20patient%20receiving%20high-dose%20chemotherapy%20for%20multiple%20myeloma&rft.jtitle=Southern%20medical%20journal%20(Birmingham,%20Ala.)&rft.au=Fleming,%20D%20R&rft.date=1997-03-01&rft.volume=90&rft.issue=3&rft.spage=364&rft.epage=365&rft.pages=364-365&rft.issn=0038-4348&rft_id=info:doi/10.1097/00007611-199703000-00022&rft_dat=%3Cpubmed_cross%3E9076316%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/9076316&rfr_iscdi=true